About this trial

Introduction: Regular practice of exercise or physical activity (PA) is a recognized intervention as a determinant of good health acquisition, maintenance, or recovery for a large number of chronic pathologies. Nevertheless, few studies have evaluated adherence to an initial health-adapted PA (APA) program, and persistence of active behavior over the time in individuals with a chronic disease.

The aim of the study is to determine the brakes and levers associated with motivation and long-term compliance. In addition, the investigators aim to evaluate the cost-effectiveness of such program in term of care consumption. Finally, the investigators complete their interest for APA prescription from practitioners agreeing to enroll their patients in the present study.

Method: The investigators perform a prospective monocentric cohort, of 2024 patients affected of a chronic disease or long-term illness (LTI), enrolled from 2021 to 2024 (4 years, 506 per year), for a 16-week APA program, and followed 5 years with an annual fitness and habits of life and care consumption evaluation.

Eligibility criteria

Qualifiers

Male or female

18 years of age or older

Speaking and understanding French

Affected by a chronic pathology according to a predefined list (LTI, obesity, HTA, COPD, COVID-19 with persistent symptoms)

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Adapted Physical Activity

Treatment groups

2,024 Participants
are divided into 1 treatment group

Locations

1
Mon Stade Sports Medicine CenterF-75013, Paris France

Sponsors and collaborators

Mon Stade Sports Medicine Centre

Lead sponsor

Laboratory MOVE, Faculty of Sport Sciences, University of Poitiers, France

Collaborator

Public Health Foundation of MGEN, France

Collaborator

General Mutual Insurance of National Education, France

Collaborator